Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression...

Area of Science:

• Oncology
• Molecular Biology
• Biotechnology

Background:

• Gene expression profiling (GEP) identifies survival-predicting genes in diffuse large-B-cell lymphoma (DLBCL).
• Traditional GEP requires frozen samples, limiting analysis of most patient archives.
• Formalin-fixed, paraffin-embedded (FFPE) tissues are widely available but challenging for gene expression analysis.

Purpose of the Study:

• To develop and validate a quantitative assay for measuring prognostic gene expression in DLBCL using FFPE tissues.
• To enable the analysis of archived DLBCL samples for survival prediction.
• To correlate gene expression data from FFPE tissues with established methods.

Main Methods:

• Developed a nuclease protection assay (ArrayPlate) for quantifying mRNA in FFPE tissues.
• Validated the assay using frozen, fresh, and FFPE DLBCL samples.
• Compared gene expression results from FFPE tissues with microarray data and immunohistochemistry.

Main Results:

• The ArrayPlate assay accurately quantified gene expression in FFPE tissues, showing high correlation with frozen samples (R(2)>0.98).
• Assay performance was consistent across new and old paraffin blocks (R(2)=0.71).
• Results correlated well with microarray data and immunohistochemistry, confirming mRNA-protein agreement.

Conclusions:

• A novel assay allows reliable gene expression measurement in archived FFPE DLBCL samples.
• This method facilitates the application of GEP findings to a broader range of patient tissues.
• While not for discovery, the assay can validate prognostic gene expression in FFPE samples.